Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging

[1]  L. Medeiros,et al.  Castleman Disease. , 2019, Surgical pathology clinics.

[2]  Rania M. Seliem,et al.  Hodgkin lymphoma with an interfollicular growth pattern: A clinicopathologic study of 8 cases. , 2018, Annals of diagnostic pathology.

[3]  D. Shilling,et al.  Castleman Disease Pathogenesis. , 2018, Hematology/oncology clinics of North America.

[4]  K. Yoshizaki,et al.  The Role of Interleukin-6 in Castleman Disease. , 2018, Hematology/oncology clinics of North America.

[5]  J. Manning,et al.  Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature. , 2017, Human pathology.

[6]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[7]  N. Hijiya,et al.  Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination. , 2017, Blood.

[8]  A. Perrot,et al.  Hodgkin Lymphoma and Castleman Disease: When One Blood Disease Can Hide Another , 2017, Case reports in hematology.

[9]  H. Goldschmidt,et al.  Gene signature combinations improve prognostic stratification of multiple myeloma patients , 2016, Leukemia.

[10]  S. Hewavisenthi,et al.  Interfollicular Hodgkin's disease with histological features of Castleman's disease. , 2015, The Ceylon medical journal.

[11]  N. Munshi,et al.  Use of a claims database to characterize and estimate the incidence rate for Castleman disease , 2015, Leukemia & lymphoma.

[12]  D. Basu,et al.  Diagnostic Issues in a Case of Hodgkin Lymphoma with Castleman Like Features , 2014, Indian Journal of Hematology and Blood Transfusion.

[13]  S. Boutayeb,et al.  Coexistence of Hodgkin's Lymphoma and Castleman's Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy , 2013, Case reports in oncological medicine.

[14]  J. Cerhan,et al.  Imaging , Diagnosis , Prognosis Prognostic Signi fi cance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma , 2013 .

[15]  M. Kojima,et al.  IL-6-positive classical Hodgkin’s lymphoma co-occurring with plasma cell type of Castleman’s disease: report of a case , 2013, International Journal of Hematology.

[16]  S. Haque,et al.  Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8 , 2009, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.

[17]  D. Capello,et al.  A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy , 2007, European journal of haematology.

[18]  A. Pathare,et al.  Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease. , 2007, Pathology, research and practice.

[19]  F. Pagani,et al.  Interfollicular Hodgkin's lymphoma and Castleman's disease , 2006, Histopathology.

[20]  J. Soulier,et al.  Castleman's disease and lymphoma: Report of eight cases in HIV‐negative patients and literature review , 2002, American journal of hematology.

[21]  P. Brousset,et al.  Simultaneous occurrence of Epstein-Barr virus associated Hodgkin's disease and HHV-8 related multicentric Castleman's disease: a fortuitous event? , 2001, Journal of clinical pathology.

[22]  D. Frank,et al.  Plasma cell variant of castleman's disease occuring concurrently with Hodgkin's disease in the neck , 2001, Head & neck.

[23]  F. Cavalli,et al.  Hodgkin's and Castleman's disease in a patient with systemic mastocytosis , 1999, Annals of Hematology.

[24]  L. Medeiros,et al.  Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases. , 1994, Archives of pathology & laboratory medicine.

[25]  S. Hsu,et al.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. , 1992, The American journal of pathology.

[26]  H. Müller-Hermelink,et al.  Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. , 1991, The American journal of pathology.

[27]  C. von Kalle,et al.  Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. , 1991, Blood.

[28]  M. Humbert,et al.  In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. , 1991, European cytokine network.

[29]  P. Maheswaran,et al.  Hodgkin's disease presenting with the histological features of Castleman's disease , 1991, Histopathology.

[30]  N. L. Harris,et al.  Case 39-1990 , 1990 .

[31]  T. Komori,et al.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .

[32]  T. Colby,et al.  Interfollicular Hodgkin's disease , 1983, The American journal of surgical pathology.

[33]  B. Castleman,et al.  Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations , 1972 .

[34]  R. Lukes.  Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. , 1971, Cancer research.

[35]  B. Castleman,et al.  Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.

[36]  A. Dispenzieri.  Castleman disease. , 2008, Cancer treatment and research.

[37]  J. Diebold,et al.  [Association of Castleman's disease and Hodgkin's disease. Eight cases and review of the literature]. , 1994, Annales de pathologie.

[38]  C. Gisselbrecht,et al.  Autoimmune hemolytic anemia disclosing Hodgkin's disease associated with Castleman's disease. , 1991, Nouvelle revue francaise d'hematologie.

[39]  T. Komori,et al.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.

[40]  B. Castleman,et al.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. , 1972, Cancer.